AGAINST! There appears to be no clarification on Livent’s shorting, There appears to be no clarification on the Capital Gains Tax, This is not advice, Do Your Own Research,
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%